Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.
Identifieur interne : 001275 ( PubMed/Corpus ); précédent : 001274; suivant : 001276Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.
Auteurs : A Cristina Paulo ; Margarida Correia-Neves ; Tiago Domingos ; Alberto G. Murta ; Jorge PedrosaSource :
- PloS one [ 1932-6203 ] ; 2010.
English descriptors
- KwdEn :
- MESH :
- genetics : Influenza A virus.
- history : Influenza, Human.
- immunology : Influenza, Human.
- mortality : Influenza, Human.
- pathogenicity : Influenza A virus.
- virology : Influenza, Human.
- Disease Outbreaks, History, 20th Century, Humans, Models, Theoretical.
Abstract
It is widely accepted that the shift in case-fatality rate between waves during the 1918 influenza pandemic was due to a genetic change in the virus. In animal models, the infectious dose of influenza A virus was associated to the severity of disease which lead us to propose a new hypothesis. We propose that the increase in the case-fatality rate can be explained by the dynamics of disease and by a dose-dependent response mediated by the number of simultaneous contacts a susceptible person has with infectious ones.
DOI: 10.1371/journal.pone.0011655
PubMed: 20668679
Links to Exploration step
pubmed:20668679Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.</title>
<author><name sortKey="Paulo, A Cristina" sort="Paulo, A Cristina" uniqKey="Paulo A" first="A Cristina" last="Paulo">A Cristina Paulo</name>
<affiliation><nlm:affiliation>Life and Health Sciences Research Institute, School of Health Sciences, Universidade do Minho, Braga, Portugal. cristinapaulo@ecsaude.uminho.pt</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Correia Neves, Margarida" sort="Correia Neves, Margarida" uniqKey="Correia Neves M" first="Margarida" last="Correia-Neves">Margarida Correia-Neves</name>
</author>
<author><name sortKey="Domingos, Tiago" sort="Domingos, Tiago" uniqKey="Domingos T" first="Tiago" last="Domingos">Tiago Domingos</name>
</author>
<author><name sortKey="Murta, Alberto G" sort="Murta, Alberto G" uniqKey="Murta A" first="Alberto G" last="Murta">Alberto G. Murta</name>
</author>
<author><name sortKey="Pedrosa, Jorge" sort="Pedrosa, Jorge" uniqKey="Pedrosa J" first="Jorge" last="Pedrosa">Jorge Pedrosa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20668679</idno>
<idno type="pmid">20668679</idno>
<idno type="doi">10.1371/journal.pone.0011655</idno>
<idno type="wicri:Area/PubMed/Corpus">001275</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001275</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.</title>
<author><name sortKey="Paulo, A Cristina" sort="Paulo, A Cristina" uniqKey="Paulo A" first="A Cristina" last="Paulo">A Cristina Paulo</name>
<affiliation><nlm:affiliation>Life and Health Sciences Research Institute, School of Health Sciences, Universidade do Minho, Braga, Portugal. cristinapaulo@ecsaude.uminho.pt</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Correia Neves, Margarida" sort="Correia Neves, Margarida" uniqKey="Correia Neves M" first="Margarida" last="Correia-Neves">Margarida Correia-Neves</name>
</author>
<author><name sortKey="Domingos, Tiago" sort="Domingos, Tiago" uniqKey="Domingos T" first="Tiago" last="Domingos">Tiago Domingos</name>
</author>
<author><name sortKey="Murta, Alberto G" sort="Murta, Alberto G" uniqKey="Murta A" first="Alberto G" last="Murta">Alberto G. Murta</name>
</author>
<author><name sortKey="Pedrosa, Jorge" sort="Pedrosa, Jorge" uniqKey="Pedrosa J" first="Jorge" last="Pedrosa">Jorge Pedrosa</name>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Outbreaks</term>
<term>History, 20th Century</term>
<term>Humans</term>
<term>Influenza A virus (genetics)</term>
<term>Influenza A virus (pathogenicity)</term>
<term>Influenza, Human (history)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (mortality)</term>
<term>Influenza, Human (virology)</term>
<term>Models, Theoretical</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term>
<term>History, 20th Century</term>
<term>Humans</term>
<term>Models, Theoretical</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">It is widely accepted that the shift in case-fatality rate between waves during the 1918 influenza pandemic was due to a genetic change in the virus. In animal models, the infectious dose of influenza A virus was associated to the severity of disease which lead us to propose a new hypothesis. We propose that the increase in the case-fatality rate can be explained by the dynamics of disease and by a dose-dependent response mediated by the number of simultaneous contacts a susceptible person has with infectious ones.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20668679</PMID>
<DateCompleted><Year>2010</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>5</Volume>
<Issue>7</Issue>
<PubDate><Year>2010</Year>
<Month>Jul</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.</ArticleTitle>
<Pagination><MedlinePgn>e11655</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0011655</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is widely accepted that the shift in case-fatality rate between waves during the 1918 influenza pandemic was due to a genetic change in the virus. In animal models, the infectious dose of influenza A virus was associated to the severity of disease which lead us to propose a new hypothesis. We propose that the increase in the case-fatality rate can be explained by the dynamics of disease and by a dose-dependent response mediated by the number of simultaneous contacts a susceptible person has with infectious ones.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We used a compartment model with seasonality, waning of immunity and a Holling type II function, to model simultaneous contacts between a susceptible person and infectious ones. In the model, infected persons having mild or severe illness depend both on the proportion of infectious persons in the population and on the level of simultaneous contacts between a susceptible and infectious persons. We further allowed for a high or low rate of waning immunity and volunteer isolation at different times of the epidemic.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In all scenarios, case-fatality rate was low during the first wave (Spring) due to a decrease in the effective reproduction number. The case-fatality rate in the second wave (Autumn) depended on the ratio between the number of severe cases to the number of mild cases since, for each 1000 mild infections only 4 deaths occurred whereas for 1000 severe infections there were 20 deaths. A third wave (late Winter) was dependent on the rate for waning immunity or on the introduction of new susceptible persons in the community. If a group of persons became voluntarily isolated and returned to the community some days latter, new waves occurred. For a fixed number of infected persons the overall case-fatality rate decreased as the number of waves increased. This is explained by the lower proportion of infectious individuals in each wave that prevented an increase in the number of severe infections and thus of the case-fatality rate.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The increase on the proportion of infectious persons as a proxy for the increase of the infectious dose a susceptible person is exposed, as the epidemic develops, can explain the shift in case-fatality rate between waves during the 1918 influenza pandemic.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paulo</LastName>
<ForeName>A Cristina</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Life and Health Sciences Research Institute, School of Health Sciences, Universidade do Minho, Braga, Portugal. cristinapaulo@ecsaude.uminho.pt</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Correia-Neves</LastName>
<ForeName>Margarida</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Domingos</LastName>
<ForeName>Tiago</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Murta</LastName>
<ForeName>Alberto G</ForeName>
<Initials>AG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pedrosa</LastName>
<ForeName>Jorge</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year>
<Month>01</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2010</Year>
<Month>06</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20668679</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0011655</ArticleId>
<ArticleId IdType="pmc">PMC2909907</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Avian Dis. 2004 Apr-Jun;48(2):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15283413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2595-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19423872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1986 Apr;96(2):335-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3701045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2007 Aug 8;298(6):644-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17684187</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Theor Biol. 2007 May 7;246(1):70-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17266989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Appl Microbiol. 2001 Oct;91(4):572-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11576290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Theor Biol. 2007 Jun 21;246(4):621-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17379249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2009 Feb;15(2):346-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19193293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Jun;74(12):5460-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10823850</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2005 Jul 15;192(2):233-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15962218</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2006 Jul 27;442(7101):448-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16642006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J R Soc Interface. 2009 Dec 6;6 Suppl 6:S783-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19773292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Biol Sci. 2008 Mar 7;275(1634):501-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18156123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2007 Jan 18;445(7125):319-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17230189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2007 Apr;7(4):257-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17376383</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2007;2(11):e1220</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18043733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2009 Aug;137(8):1062-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19215637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3645-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19276125</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2006 Dec 23;368(9554):2211-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17189032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1303-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18216264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Gesamte Virusforsch. 1969;26(3):225-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5782934</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2008 Jan 15;197(2):270-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18194088</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Dec 16;432(7019):904-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15602562</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Equine Vet J. 1990 Mar;22(2):93-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2156688</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viral Immunol. 2003;16(1):57-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12725689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2002 Feb;2(2):111-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11901642</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3243-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19204283</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2008 Nov;57(5):361-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18848358</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2007 Apr;13(4):590-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17553274</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Z Med J. 2007;120(1256):U2579</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17589547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2009 May;3(3):99-106</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19453486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Oct 7;431(7009):703-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15470432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1829-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11779381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1986 Jan;153(1):33-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3941288</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc R Soc Med. 1958 Dec;51(12):1009-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13623821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Z Med J. 2008 Oct 17;121(1284):18-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18953383</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18332436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2008 Nov 15;198(10):1427-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18808337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2005 Jan 4;23(7):940-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15603896</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Dec;79(23):14933-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16282492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2003 Oct;9(10):1249-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14609459</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2008 Apr 1;167(7):775-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18230677</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2006 Jan;12(1):9-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16494710</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2006 Jan;12(1):88-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16494723</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2008 Feb;136(2):166-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17445311</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2007 Feb 2;315(5812):655-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17272724</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1941 Jan 1;73(1):43-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19871064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1939 Jan 31;69(2):283-300</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19870847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Occup Environ Hyg. 2008 Jun;5(6):347-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18357546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2009;4(3):e4857</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19293935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2008 Oct 1;198(7):962-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18710327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Soc Sci Med. 2006 Feb;62(4):923-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16084634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2008;3(1):e1498</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18231585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2007 Feb 2;315(5812):582</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17272689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1984 Feb;92(1):125-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6693762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1980 Aug;29(2):654-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7216433</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16915-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15557003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2001 Sep 7;293(5536):1842-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11546876</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2006 Jan;12(1):15-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16494711</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001275 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001275 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:20668679 |texte= Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:20668679" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
![]() | This area was generated with Dilib version V0.6.34. | ![]() |